Mario Miele
About Mario Miele
Mario Miele serves as the Senior Vice President of Facilities & Engineering at ElevateBio, a position he has held since 2022. He has extensive experience in the biotechnology sector, having previously worked at AbbVie and contributed to significant projects such as the BaseCamp manufacturing facility.
Work at ElevateBio
Mario Miele has been serving as the Senior Vice President of Facilities & Engineering at ElevateBio since 2022. In this role, he oversees the facilities and engineering operations, contributing to the company's mission in the biotechnology sector. Prior to his current position, he held the role of Vice President, Facilities and Engineering at ElevateBio from 2020 to 2022. His tenure at ElevateBio began as Senior Director, Facilities and Engineering from 2019 to 2020, where he was instrumental in various projects, including the development of advanced manufacturing facilities.
Education and Expertise
Mario Miele earned a Bachelor of Science (BS) in Chemical Engineering from Worcester Polytechnic Institute, where he studied from 1992 to 1996. He furthered his education by obtaining a Master of Science (MS) in Management from the same institution. His expertise lies in facilities and engineering within the biotechnology sector, with a focus on manufacturing processes and facility management.
Background
Before joining ElevateBio, Mario Miele worked at AbbVie for over a decade, where he held various engineering and management positions. He served as Project Engineering Manager from 2004 to 2014, followed by roles as Director of Engineering, Maintenance, and EHS from 2016 to 2019, and Manufacturing and Facility Engineering Manager from 2014 to 2016. His extensive experience in the biotechnology field has equipped him with the skills necessary for leading complex engineering projects.
Achievements
Mario Miele has been recognized for his leadership in the biotechnology sector, particularly for driving the completion of a state-of-the-art facility during the pandemic. He played a significant role in the buildout of BaseCamp, a cell and gene therapy manufacturing facility, which highlights his commitment to advancing biotechnology infrastructure.